EcoR1 Capital’s Frazier Lifesciences Acquisition Corporation Warrant FLACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-66,665
Closed -$665K – 81
2022
Q3
$665K Hold
66,665
– – 0.02% 73
2022
Q2
$658K Hold
66,665
– – 0.02% 72
2022
Q1
$655K Hold
66,665
– – 0.02% 82
2021
Q4
$650K Hold
66,665
– – 0.02% 72
2021
Q3
$655K Hold
66,665
– – 0.02% 65
2021
Q2
$651K Buy
+66,665
New +$66.5K 0.02% 68

EcoR1 Capital's FLACW Position: Q4 2022 in Review

EcoR1 Capital sold out of Frazier Lifesciences Acquisition Corporation Warrant (FLACW) in Q4 2022, closing a stake of 66,665 shares — an estimated $665K sold.

EcoR1 Capital first reported a position in FLACW in Q2 2021 and held it in 6 quarters. The position peaked at $665K in Q3 2022. 0 funds tracked by Wall St. Rank hold FLACW as of Q4 2022.

  • EcoR1 Capital reported no remaining Frazier Lifesciences Acquisition Corporation Warrant position as of Q4 2022 after selling out during the quarter.
  • EcoR1 Capital sold 66,665 Frazier Lifesciences Acquisition Corporation Warrant shares in Q4 2022, an estimated $665K.
  • EcoR1 Capital first reported a position in Frazier Lifesciences Acquisition Corporation Warrant in Q2 2021 and held it in 6 quarters.
  • EcoR1 Capital's Frazier Lifesciences Acquisition Corporation Warrant position peaked at $665K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Warrant as of Q4 2022.

Based on EcoR1 Capital's 13F filing for Q4 2022, filed 14 Feb 2023.